Workflow
“A+H”潮起 致同香港审计主管合伙人吴嘉江:A股公司赴港上市“五注意”
Zheng Quan Shi Bao Wang·2025-05-27 09:51

Core Viewpoint - Many mainland companies are actively expanding their international business, with a focus on capital operations and strategic layout, utilizing Hong Kong as a crucial hub for global competition [1] Group 1: Market Trends - In 2023, companies like CATL and Hengrui Medicine have successfully listed in Hong Kong, with over 40 A-share companies announcing plans to list or have submitted applications [1] - The "A+H" dual listing model is gaining momentum, driven by the influx of Chinese concept stocks returning to Hong Kong, creating a capital migration wave [1] Group 2: Policy and Institutional Support - Recent measures supporting collaboration between the capital market and Hong Kong have accelerated the "A+H" operations, with the Hong Kong Stock Exchange's innovations playing a significant role [2] - The introduction of the "Specialized Technology and Biotech Companies" route allows companies to submit applications confidentially, addressing the challenge of protecting commercial secrets during the R&D phase [2] Group 3: Advantages of Hong Kong - Hong Kong's status as an international financial center offers multiple advantages, including a connectivity mechanism, refinancing convenience, offshore RMB business hub, and green finance development [2] Group 4: Recommendations for Companies - Companies are advised to choose the appropriate listing model based on strategic goals, optimize corporate governance to meet Hong Kong's listing requirements, and assess financial conditions to ensure compliance with key metrics [3][4] - It is crucial for companies to prepare for financial and legal compliance early, conducting thorough due diligence to avoid regulatory issues that could delay the listing process [3] - Companies should also stay attuned to market conditions and policy changes, optimizing their listing strategies to maximize efficiency [4]